UTRECHT, The Netherlands, – July 10, 2022 – Bruker is delighted to announce that Professor Harald Schwalbe of the Goethe University in Frankfurt Germany is this year’s winner of the prestigious Richard R. Ernst Prize in Magnetic Resonance.
Professor Schwalbe is being recognized for his seminal contributions to the development and application of original methods in biomolecular NMR spectroscopy; in particular for the new insight that he and his group have shed on the fields of RNA and DNA folding and regulation, for the elucidation of the folding pathways that ordered and disordered proteins exhibit in vitro, and for ingenious new proposals on how to use NMR for drug screening and drug design leading to practical useful applications. Professor Schwalbe is also being praised for his efforts in the creation of the international scientific “collaboratorium”, to unravel molecular aspects related to the COVID-19 pandemic by NMR and other methods.
Lucio Frydman, Chair of the Award Committee and Professor at the Weizmann Institute
Professor Harald Schwalbe of the Goethe University in Frankfurt Germany
The Richard R. Ernst Prize was founded by EUROMAR with sponsor Bruker in 2017 to recognize recent beneficial methods and applications in Magnetic Resonance research. Named after the 1991 Nobel Prize in Chemistry awardee Prof. Richard R. Ernst for his seminal contributions to the development of high resolution nuclear magnetic resonance (NMR)
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.